These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2896641)

  • 1. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM; Nguyen KP; Giacomini JC; Lee DA
    J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
    Mittag TW; Tormay A; Messenger M; Podos SM
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of l- and d-timolol on cyclic AMP synthesis and intraocular pressure in water-loaded, albino and pigmented rabbits.
    Liu JH; Bartels SP; Neufeld AH
    Invest Ophthalmol Vis Sci; 1983 Sep; 24(9):1276-82. PubMed ID: 6309696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure control.
    Himber J; Velly J; Kintz P; de Burlet G; Andermann G; Leclerc G
    Methods Find Exp Clin Pharmacol; 1989 May; 11(5):315-21. PubMed ID: 2547127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits.
    Chidlow G; Nash MS; De Santis LM; Osborne NN
    Exp Eye Res; 1999 Dec; 69(6):587-93. PubMed ID: 10620387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of beta-adrenoceptor subtype involvement in the ocular hypotensive response to beta-adrenergic stimulation.
    Woodward DF; Chen J; Padillo E; Ruiz G
    Exp Eye Res; 1986 Jul; 43(1):61-75. PubMed ID: 2874044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
    Sharif NA; Xu SX; Crider JY; McLaughlin M; Davis TL
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):305-17. PubMed ID: 11572462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the ocular and extraocular pharmacology of metipranolol.
    Sugrue MF; Armstrong JM; Gautheron P; Mallorga P; Viader MP
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(3):123-7. PubMed ID: 2858433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation.
    Kanno M; Araie M; Tomita K; Sawanobori K
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):736-43. PubMed ID: 9538880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical beta-blockers on the diameter of the isolated porcine short posterior ciliary artery.
    Braakman R; van der Linden P; Sipkema P
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):370-7. PubMed ID: 9950595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive and vasodilative effects of two beta-adrenergic blockers with intrinsic sympathomimetic activity.
    Hong SJ; Wu KY; Chen IJ
    Curr Eye Res; 1998 Jul; 17(7):700-7. PubMed ID: 9678415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process.
    Nathanson JA
    J Pharmacol Exp Ther; 1988 Apr; 245(1):94-101. PubMed ID: 2896241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of plasma kinetics and beta-receptor binding and -blocking activity of timolol following its small intravenous dose.
    Kaila T; Karhuvaara S; Huupponen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):351-7. PubMed ID: 8103764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.